Fmc corporation to introduce strategic growth plan at investor day, details cost restructuring and provides preliminary 2024 outlook

2024 full-year preliminary outlook 1 revenue of $4.65 billion to $4.85 billion, reflecting 3 percent increase midpoint to midpoint from latest 2023 guidance adjusted ebitda of $1.025 billion to $1.125 billion, reflecting 8 percent increase midpoint to midpoint from latest 2023 guidance $50 million to $75 million of adjusted ebitda contribution in 2024 from restructuring actions with approximately $150 million of run-rate savings by the end of 2025 adjusted earnings per share expected to grow faster than adjusted ebitda in 2024 return on invested capital over 10 percent free cash flow conversion of over 100 percent expect to end 2024 approaching historically normal leverage metrics 2026 goals 1 revenue of $5.5 billion to $6.0 billion adjusted ebitda of $1.3 billion to $1.5 billion adjusted earnings per share are expected to grow faster than adjusted ebitda free cash flow conversion on rolling three-year average of at least 70 percent return on invested capital in the mid-teens percent target approximately 2x net debt to adjusted ebitda on a rolling four quarter average basis philadelphia , nov. 16, 2023 /prnewswire/ -- fmc corporation (nyse:fmc) will host its investor day later today at fmc corporate headquarters in philadelphia where the company will outline its long-range strategic growth plan, including updated long-term financial targets, a review of the company's r&d pipeline and a discussion about fmc's newest synthetic and biological product portfolios. in addition, the company will further detail its restructuring plan and provide a preliminary outlook for 2024.
FMC Ratings Summary
FMC Quant Ranking